$17.59
0.311.79%
At close: -
$17.20
-0.39-2.22%
After Hours: Dec 20, 4:21 PM EDT
Comments
Loading...
Entrada Therapeutics (NASDAQ:TRDA) Stock, Earnings Estimates, EPS, And Revenue
Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 12
EPS Estimate
$-0.800
Quarterly Revenue Estimate
$9.1M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$215.2M
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Entrada Therapeutics (TRDA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-05 | $-0.35 | $-0.73 | 52.0 % |
| Jun 2024 | 2024-08-13 | $1.55 | $0.14 | 1007.1 % |
| Mar 2024 | 2024-05-07 | $0.68 | $-0.59 | 215.3 % |
| Dec 2023 | 2024-03-13 | $-0.29 | $-0.17 | -70.6 % |
Entrada Therapeutics (TRDA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-05 | $19.57M | $12.32M | 58.9 % |
| Jun 2024 | 2024-08-13 | $94.69M | $46.07M | 105.5 % |
| Mar 2024 | 2024-05-07 | $59.12M | $14.98M | 294.7 % |
| Dec 2023 | 2024-03-13 | $41.85M | $23.69M | 76.6 % |
FAQ
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics (TRDA) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
What were the latest earnings per share (EPS) for Entrada Therapeutics (NASDAQ:TRDA)?
The Actual EPS was $-0.35, which beat the estimate of $-0.73.
What were Entrada Therapeutics’s (NASDAQ:TRDA) revenues?
The Actual Revenue was $19.6M, which beat the estimate of $12.3M.
Browse earnings estimates, EPS, and revenue on all stocks.